Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine.

Siripassorn K, Manosuthi W, Pakdee A, Natprom S, Chaovavanich A, Hengphadpanadamrong N, Woratanarat K, Lueangniyomkul A, Ruxrungtham AK; Bamrasnaradura study team.

AIDS Res Ther. 2013 Jan 25;10(1):4. doi: 10.1186/1742-6405-10-4.

2.

HIVQUAL-T: monitoring and improving HIV clinical care in Thailand, 2002-08.

Thanprasertsuk S, Supawitkul S, Lolekha R, Ningsanond P, Agins BD, McConnell MS, Fox KK, Srisongsom S, Chunwimaleung S, Gass R, Simmons N, Chaovavanich A, Jirajariyavej S, Leusaree T, Akksilp S, Mock PA, Chasombat S, Lertpiriyasuwat C, Tappero JW, Levine WC.

Int J Qual Health Care. 2012 Aug;24(4):338-47. doi: 10.1093/intqhc/mzs008. Epub 2012 Jun 3.

PMID:
22665387
3.

Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.

Sirikwin S, Likanonsakul S, Waradejwinyoo S, Pattamadilok S, Kumperasart S, Chaovavanich A, Manatsathit S, Malerczyk C, Wasi C.

Vaccine. 2009 Jul 9;27(32):4350-4. doi: 10.1016/j.vaccine.2009.03.027. Epub 2009 Apr 3.

PMID:
19487057
4.

Indicators for sexual HIV transmission risk among people in Thailand attending HIV care: the importance of positive prevention.

Tunthanathip P, Lolekha R, Bollen LJ, Chaovavanich A, Siangphoe U, Nandavisai C, Suksripanich O, Sirivongrangson P, Wiratchai A, Inthong Y, Eampokalap B, Ausavapipit J, Akarasewi P, Fox KK.

Sex Transm Infect. 2009 Feb;85(1):36-41. doi: 10.1136/sti.2008.032532. Epub 2008 Oct 16.

PMID:
18927180
5.

Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.

Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chaovavanich A.

J Med Assoc Thai. 2008 Feb;91(2):159-65.

PMID:
18389979
6.

Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study.

Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Prasithsirikul W, Athichathanabadi C, Likanonsakul S, Chaovavanich A.

Curr Ther Res Clin Exp. 2008 Feb;69(1):90-100. doi: 10.1016/j.curtheres.2008.02.007.

7.

Evaluation of HIV-1 viral load detection by modified a commercial real-time PCR reagent used for Light Cycler 1.2 instrument.

Uttayamakul S, Likanonsakul S, Sutthent R, Chaovavanich A.

J Med Assoc Thai. 2007 Nov;90(11):2429-36.

PMID:
18181331
8.

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.

Manosuthi W, Sungkanuparph S, Ruxrungtham K, Prasithsirikul W, Athichathanabadi C, Tantisiriwat W, Bowonwatanuwong C, Chumpathat N, Chaovavanich A.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):127-9. No abstract available.

PMID:
18156994
9.

Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL.

Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Inthong Y, Prasithsirikul W, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chumpathat N, Termvises P, Chaovavanich A.

Int J STD AIDS. 2007 Nov;18(11):782-6.

PMID:
18005514
10.

Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.

Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S.

J Infect. 2007 Nov;55(5):464-9. Epub 2007 Aug 22.

PMID:
17714788
11.

Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.

Manosuthi W, Kiertiburanakul S, Chaovavanich A, Sungkanuparph S.

J Med Assoc Thai. 2007 Feb;90(2):244-50.

PMID:
17375627
12.

Survival time of AIDS patients in Bamrasnaradura Institute.

Chaovavanich A, Chottanapund S, Ausavapipit J, Adulyawat N, Ubonsai W.

J Med Assoc Thai. 2006 Nov;89(11):1859-63.

PMID:
17205866
13.

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.

Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

PMID:
16885778
14.

Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.

Manosuthi W, Sungkanuparph S, Thakkinstian A, Rattanasiri S, Chaovavanich A, Prasithsirikul W, Likanonsakul S, Ruxrungtham K.

Clin Infect Dis. 2006 Jul 15;43(2):253-5. Epub 2006 Jun 12.

PMID:
16779754
15.

Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project.

Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Virapat P, Tunthanathip P, Ausavapipit J, Lokpichat S, Siangphoe U, Jirarojwat N, Pobkeeree V, Supawitkul S, Tappero JW, Levine WC.

Sex Transm Dis. 2007 Feb;34(2):104-7.

PMID:
16755274
16.

Sexually transmitted infection services as a component of HIV care: findings of a demonstration project among HIV-infected women in Thailand.

Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Jirarojwat N, Virapat P, Charoenwatanachokchai A, Lokpichat S, Pobkeeree V, Chantharojwong N, Supawitkul S, Tappero JW, Levine WC.

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):671-4.

PMID:
16652043
18.

Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection.

Uttayamakul S, Likanonsakul S, Sunthornkachit R, Kuntiranont K, Louisirirotchanakul S, Chaovavanich A, Thiamchai V, Tanprasertsuk S, Sutthent R.

J Virol Methods. 2005 Sep;128(1-2):128-34.

PMID:
15913797
19.

Early containment of severe acute respiratory syndrome (SARS); experience from Bamrasnaradura Institute, Thailand.

Chaovavanich A, Wongsawat J, Dowell SF, Inthong Y, Sangsajja C, Sanguanwongse N, Martin MT, Limpakarnjanarat K, Sirirat L, Waicharoen S, Chittaganpitch M, Thawatsupha P, Auwanit W, Sawanpanyalert P, Melgaard B.

J Med Assoc Thai. 2004 Oct;87(10):1182-7.

PMID:
15560695
20.

Severe acute respiratory syndrome coronavirus on hospital surfaces.

Dowell SF, Simmerman JM, Erdman DD, Wu JS, Chaovavanich A, Javadi M, Yang JY, Anderson LJ, Tong S, Ho MS.

Clin Infect Dis. 2004 Sep 1;39(5):652-7. Epub 2004 Aug 11.

PMID:
15356778
21.

Antifungal susceptibilities of Cryptococcus neoformans.

Archibald LK, Tuohy MJ, Wilson DA, Nwanyanwu O, Kazembe PN, Tansuphasawadikul S, Eampokalap B, Chaovavanich A, Reller LB, Jarvis WR, Hall GS, Procop GW.

Emerg Infect Dis. 2004 Jan;10(1):143-5.

22.

Maternal and umbilical cord serum vitamin A, E levels and mother-to-child transmission in the non-supplemented vitamin A, E HIV-1 infected parturients with short-course zidovudine therapy.

Wiratchai A, Phuapradit W, Sunthornkachit R, Chaovavanich A, Tantanathip P, Puchaiwatananon O.

J Med Assoc Thai. 1999 Sep;82(9):885-90.

PMID:
10561944
23.

Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.

Phuapradit W, Sirinavin S, Taneepanichskul S, Chaovavanich A, Wiratchai A, Sunthornkachit R, Puchaiwatanon O.

Aust N Z J Obstet Gynaecol. 1998 Aug;38(3):288-92.

PMID:
9761155

Supplemental Content

Loading ...
Support Center